Relative Bioavailability Study of Lipidil® Supra (Fenofibrate 160mg) Versus SYO-0805 (Fenofibrate 65mg)
Clinical trial NCT01353404 · COMPLETED
Trial details
- NCT number
- NCT01353404
- Sponsor
- Samyang Biopharmaceuticals Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2011-08-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.